增长分化因子15在心力衰竭与保存的喷射分数的诊断和预后影响:系统性审查和元分析
Iwan Dakota1,2, Matthew Aldo Wijayanto1,3, Annisa Salsabilla Dwi Nugrahani4
1National Cardiovascular Center Harapan Kita, West Jakarta, Jakarta, Indonesia.
PeerJ
|November 3, 2025
概括
增长差异化因子-15 (GDF-15) 显示出作为心力衰竭的生物标志物具有保留喷射分数 (HFpEF) 的承诺. 较高的GDF-15水平与较差的结果有关,包括死亡率和住院治疗.
科学领域:
- 心脏病学 心脏病学
- 生物标志物 生物标志物
- 炎症研究 炎症研究
背景情况:
- 增长差异化因子-15 (GDF-15) 是一种与慢性炎症和氧化应激相关的新兴生物标志物.
- 它显示了潜在的诊断和预后意义心力衰竭与保存的喷射分数 (HFpEF).
研究的目的:
- 评估GDF-15在识别HFpEF时的诊断准确性.
- 评估GDF-15在HFpEF患者死亡率和住院病例方面的预后价值.
主要方法:
- 在PubMed,Scopus和ScienceDirect进行了系统的文献搜索.
- 包括12项观察性研究,涉及5696名HFpEF患者,使用纽卡斯尔-太华尺度评估质量.
- 用随机效应模型进行了元分析,并进行了灵敏度分析以确保稳定性.
主要成果:
- 在HFpEF患者中,GDF-15水平显著升高 (总体MD:647.60 pg/mL).
- GDF-15显示出良好的诊断准确性 (AUC:0.82),并且表现优于常规生物标志物.
- 升高的GDF-15与全因死亡率 (HR: 1.46) 和心力衰竭住院治疗 (HR: 1.76) 的风险增加有关.
结论:
- GDF-15是诊断HFpEF的一个有价值的生物标志物.
- 较高的GDF-15水平表明预后更差,与HFpEF的死亡率和住院风险增加相关.
相关概念视频
Pathophysiology of Heart Failure
2.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.8K
Heart Failure IV: Classification and Diagnostic Evaluation
310
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
310
Heart Failure II: Pathophysiology
699
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
699
Cardiomyopathy II: Dilated Cardiomyopathy
455
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
455
Heart Failure V: Medical Management
208
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
208
Heart Failure I: Introduction
673
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
673


